The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

Tubulis has dosed the first subject in the multicentre Phase I/IIa 5-STAR 1-01 trial to clinically evaluate its second drug ...

In a world overwhelmed with conflicting information about weight loss, AquaSculpt emerges as a beacon of hope for those ...